Imipenem-Cilastatin-Mepha i.v.
Imipenem-Cilastatin-Mepha i.v. is a medicine authorised by Swissmedic under authorisation number 60262. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 24 June 2010 and the authorisation is valid without a time limit. ATC code J01DH51 places the medicine in the group Antibacterials for systemic use.
| Authorisation number | 60262 |
|---|---|
| Name | Imipenem-Cilastatin-Mepha i.v. |
| Full name | Imipenem-Cilastatin-Mepha i.v., Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J01DH51 |
| First authorisation | 24 June 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Imipenem-Cilastatin-Mepha i.v., Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 24 June 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 10 | Durchstechflasche(n) | J01DH51 | 08.01.93 | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Imipenem-Cilastatin-Mepha i.v. authorised in Switzerland?
Yes. Imipenem-Cilastatin-Mepha i.v. is authorised by Swissmedic under authorisation number 60262, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Imipenem-Cilastatin-Mepha i.v. have?
Imipenem-Cilastatin-Mepha i.v. is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Imipenem-Cilastatin-Mepha i.v.?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.